GTII Share Price Performance
GTII Community Fair Values
- CA$17.28FV46.1% undervalued intrinsic discount4.43%Revenue growth p.a.0users have liked this narrative0users have commented on this narrative10users have followed this narrative2 days ago author updated this narrative
- CA$10.77FV13.5% undervalued intrinsic discount3.64%Revenue growth p.a.0users have liked this narrative0users have commented on this narrative0users have followed this narrative9 days ago author updated this narrative
- CA$22.91FV59.3% undervalued intrinsic discount5.78%Revenue growth p.a.0users have liked this narrative0users have commented on this narrative0users have followed this narrative9 days ago author updated this narrative
Recent GTII News & Updates
No updates
Green Thumb Industries Inc. Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
Aug 06, 2025
- Earnings per share (EPS)
- 0.22
- Gross Margin
- 52.54%
- Net Profit Margin
- 4.41%
- Debt/Equity Ratio
- 14.0%
Green Thumb Industries Inc. Competitors
About GTII
- Founded
- 2014
- Employees
- 4900
- CEO
- WebsiteView website
Green Thumb Industries Inc. manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, tinctures, edibles, topicals, capsules, tinctures, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles, and RHYTHM brands. It distributes its products to third-party licensed retail customers; and sells finished products directly to consumers through its retail stores, as well as direct-to-consumer delivery channel. Green Thumb Industries Inc. was founded in 2014 and is headquartered in Chicago, Illinois.
U.S. Market Performance
- 7 Days: -0.6%
- 3 Months: 11.8%
- 1 Year: 16.8%
- Year to Date: 7.5%
In the last week, the market has been flat, with a notable exception in the Healthcare sector dropping 4.2%. As for the longer term, the market has risen 17% in the past 12 months. As for the next few years, earnings are expected to grow by 15% per annum. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading